GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (LSE:GENF) » Definitions » EV-to-Revenue

Genflow Biosciences (LSE:GENF) EV-to-Revenue : (As of May. 23, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Genflow Biosciences EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Genflow Biosciences's enterprise value is £3.24 Mil. Genflow Biosciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was £0.00 Mil. Therefore, Genflow Biosciences's EV-to-Revenue for today is .

The historical rank and industry rank for Genflow Biosciences's EV-to-Revenue or its related term are showing as below:

LSE:GENF's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 7.17
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-05-23), Genflow Biosciences's stock price is £0.009. Genflow Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was £0.00. Therefore, Genflow Biosciences's PS Ratio for today is .


Genflow Biosciences EV-to-Revenue Historical Data

The historical data trend for Genflow Biosciences's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genflow Biosciences EV-to-Revenue Chart

Genflow Biosciences Annual Data
Trend Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
- - - -

Genflow Biosciences Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-Revenue Get a 7-Day Free Trial - - - - -

Competitive Comparison of Genflow Biosciences's EV-to-Revenue

For the Biotechnology subindustry, Genflow Biosciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genflow Biosciences's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genflow Biosciences's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Genflow Biosciences's EV-to-Revenue falls into.


;
;

Genflow Biosciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Genflow Biosciences's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=3.241/0
=

Genflow Biosciences's current Enterprise Value is £3.24 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genflow Biosciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genflow Biosciences  (LSE:GENF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Genflow Biosciences's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.009/0
=

Genflow Biosciences's share price for today is £0.009.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2024 was £0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genflow Biosciences EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Genflow Biosciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Genflow Biosciences Business Description

Traded in Other Exchanges
Address
6 Heddon Street, London, GBR, W1B 4BT
Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.

Genflow Biosciences Headlines

No Headlines